Dr Joseph Sinkule named president and COO of Compass Biotechnologies
This article was originally published in Scrip
Compass Biotechnologies has appointed Dr Joseph Sinkule president and chief operating officer. He recently played a leading role in directing the company towards the bio betters, generic drug markets and development of biosimiliar blockbuster products. In his new role, Dr Sinkule will take charge of the hepatitis drug development programme of C-Pharma, a subsidiary of Compass.